440 related articles for article (PubMed ID: 31914172)
1. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.
Liu P; Pan X; Chen C; Niu T; Shuai X; Wang J; Chen X; Liu J; Guo Y; Xie L; Wu Y; Liu Y; Liu T
Blood; 2020 Mar; 135(11):826-833. PubMed ID: 31914172
[TBL] [Abstract][Full Text] [Related]
2. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
3. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
4. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
6. An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis.
Xu Y; Li W; Gan J; He X; Huang X
Ann Hematol; 2023 Dec; 102(12):3325-3333. PubMed ID: 37787838
[TBL] [Abstract][Full Text] [Related]
7. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Cheng CN; Chu WY; Chang KC; Chen JS
J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
[TBL] [Abstract][Full Text] [Related]
9. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
[TBL] [Abstract][Full Text] [Related]
12. PD-1 blockade with nivolumab-controlled Epstein-Barr virus infection and associated haemophagocytic lymphohistiocytosis: a case report.
Dong LH; Liu J; Zu P; Gao X; Du JW; Wang YS; Li YF
Clin Microbiol Infect; 2019 Nov; 25(11):1438-1440. PubMed ID: 31229591
[No Abstract] [Full Text] [Related]
13. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
14. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
17. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
18. Virus-triggered secondary hemophagocytic lymphohistiocytosis.
Imashuku S; Morimoto A; Ishii E
Acta Paediatr; 2021 Oct; 110(10):2729-2736. PubMed ID: 34096649
[TBL] [Abstract][Full Text] [Related]
19. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Li Y; Li S; Lu N; Wang W; Wang D
Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
